Stockhead on MSN59m
Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure
One of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...
Amy Schumer having 'good experience' with new weight loss drug after suffering severe Ozempic side effects
Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult time using Ozempic years ago.